Nara, Japan

Yuji Koriyama

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Shionogi Company Limited, Bayer Aktiengesellschaft, Actimis Pharmaceuticals, Inc.. Active years: 2003-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuji Koriyama. Retrieved from https://idiyas.com/inventor/yuji-koriyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 12.4

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • Nara, JP (2003)
  • Nara-ken, JP (2006 - 2008)
  • Kusatsu, JP (2010 - 2011)
  • Osaka, JP (2012 - 2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Yuji Koriyama: Innovator in Pharmaceutical Chemistry

Introduction

Yuji Koriyama is a prominent inventor based in Nara-ken, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential. With a total of 12 patents to his name, Koriyama's work has garnered attention in the scientific community.

Latest Patents

Among his latest innovations are the Aminodihydrothiazine derivatives, which are compositions exhibiting BACE 1 inhibitory activity. These compounds are represented by a specific formula, showcasing Koriyama's expertise in creating effective pharmaceutical agents.

Career Highlights

Throughout his career, Yuji Koriyama has worked with notable companies such as Shionogi Company Limited and Bayer Aktiengesellschaft. His experience in these esteemed organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Koriyama has collaborated with talented individuals in his field, including Hiroki Sato and Takuya Shintani. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Yuji Koriyama's contributions to pharmaceutical chemistry and his impressive portfolio of patents highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic agents, making a lasting impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…